NXS 0.00% 22.5¢ next science limited

Ann: Appendix 4C & Quarterly Activity Report - 31 December 2023, page-10

  1. 230 Posts.
    lightbulb Created with Sketch. 147
    When you are growing at 80% compound per annum and adding new customers daily, to expect your quarterly cashflow from sales to equal your quarterly revenue is just silly. I doubt they have many customers who are on a cash only basis. Most of their customers would have negotiated at least 30 days and probably more to pay their accounts. A fair few of their customers are huge hospital groups or medical conglomerates. As a consequence, there will always be a lag between a sale and receipt of cash and in a business growing like the clappers, this is even more pronounced.
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
(20min delay)
Last
22.5¢
Change
0.000(0.00%)
Mkt cap ! $65.73M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
2 19007 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 272 1
View Market Depth
Last trade - 07.02am 26/08/2024 (20 minute delay) ?
NXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.